Corporate Events

Sinopec Shanghai Gaoqiao Company signed a letter of intent to acquire remaining 50% stake in Shanghai Sinopec Mitsui Chemicals, Co., Ltd. from Mitsui Chemicals, Inc. (TSE:4183) on June 24, 2025. Upon completion, Sinopec Shanghai Gaoqiao Company will own 100% stake in Shanghai Sinopec Mitsui Chemicals, Co., Ltd. For the period ending March 31, 2025, Shanghai Sinopec Mitsui Chemicals, Co., Ltd. reported total revenue of ¥45.8 billion. As of March 31, 2025, Shanghai Sinopec Mitsui Chemicals, Co., Ltd. reported total assets of ¥29.92 billion and total common equity of ¥28.07 billion. The expected completion of the transaction is October 1, 2025 to October 31, 2025. The agreement is scheduled to be signed at the end of June 2025.

Mitsui Chemicals Group will exhibit at the ProPak Asia 2025 from 11 to 14 June 2025, at Bangkok International Trade & Exhibition Centre (BITEC) in Thailand. With the growing focus on sustainability in packaging solutions, Mitsui Chemicals Group will present close to 10 products that can be applied to various sustainable packaging requirements. In addition, new prototypes will be on display for booth visitors to experience the different application structures using products. Prototypes on display: Recycle-ready polypropylene-based pouch; Maximized single polymer material; High barrier sealable BOPP film to reduce overall virgin plastic use. Recycle-ready polyolefin-based pouch; Suitable for acidic product packaging; Special EVOLUE grade to allow seal through contamination; TAKELAC/TAKENATE combination to retain adhesion under aggressive environment; De fold film; Polyethylene-based film modified using Mitsui Chemicals product; Retain folding property after removal of pressure; Suitable for diverse industries' applications; Printable PCR film; Mechanical PCR (Re'PRM™?) based mono-layer film with low gel content for film surface printing; Suitable for regular FMCG products' secondary packaging; Mono-polyethylene pouch with PCR content; Combining Re'PRM™? resin with EVOLUE™? high-performance polyethylene resin; Offers enhanced sealability and improved pouch appearance, thus achieving a balance of sustainability and premium packaging aesthetics.

Mitsui Chemicals, Inc. Presents at ProPak Asia 2025, Jun-11-2025 . Venue: Bangkok International Trade & Exhibition Centre (BITEC), Bangkok, Thailand.

Mitsui Chemicals, Inc. announced the launch of its second Corporate Venture Capital Fund ‘321Catalyst™.’ Building on the success of its first fund, ‘321FORCE™,’ which was launched with Japanese venture capital Global Brain in 2022, 321Catalyst™’s mission will be to accelerate the building of global innovation partnerships and the launching of new products and businesses. Through the establishment of the new, independent fund in the USA, Mitsui Chemicals is doubling down on global investments in innovative startups that align with its strategic focus. Strong innovation partnerships with its portfolio companies will allow Mitsui Chemicals to launch new businesses ahead of the race. 321Catalyst™ will have a fund size of $60 million and a life of 10 years. Mitsui Chemicals intends to enhance and strengthen its Basic Strategy of ‘building solutions-based business models’ as manifested in its Long-Term Business Plan, VISION 2030. Consistent with this goal, Mitsui Chemicals will continue investing in startups across the world to escalate the launching of new products and new businesses as well as the transformation of its business portfolio. The overview of 321Catalyst™, the new Corporate Venture Capital Fund, includes the registered name 321Catalyst LP, an address in San Jose, CA, USA, a fund size of 60 million, a date of establishment on May 6, 2025, a fund life of 10 years, a focus stage of seed and at all stages beyond, a focus region that is global (USA, Europe, Asia, etc.), and a focus industry that encompasses all industries including Life & Healthcare, Mobility, ICT, Sustainability, and other new industries. The General Partner is 321Catalyst Ventures, Inc., and the Limited Partner is 321Indigo Ventures, Inc.

Sojitz Corporation (TSE:2768) agreed to acquire 66.50% stake in Nippon A&L Inc. from Sumitomo Chemical Company, Limited (TSE:4005) and Mitsui Chemicals, Inc. (TSE:4183) on May 15, 2025. The expected completion of the transaction is July 2025.

Mitsui Chemicals, Inc., Annual General Meeting, Jun 24, 2025, at 10:00 Tokyo Standard Time. Location: Nihonbashi Mitsui Hall, 4th floor of Coredo Muromachi 1, 2-1, Nihonbashi-Muromachi 2-chome, Chuo-ku, Tokyo, Japan Tokyo Japan Agenda: To consider the business report, consolidated financial statements and the results of auditing consolidated financial statements by accounting auditors and board of corporate auditors for the 28th fiscal year (April 1, 2024 to March 31, 2025); to consider the non-consolidated financial statements for the 28th fiscal year (April 1, 2024 to March 31, 2025); to consider the appropriation of surplus; to consider the election of eight directors; and to consider other business matters.

Mitsui Chemicals, Inc. provided consolidated earnings guidance for full year 2025. For the year, the company expects sales revenue to be JPY 1,770.0 billion, Operating income before special items is expected to be JPY 110.0 billion, and net income attributable to owners of the parent is expected to be JPY 55.0 billion.

Mitsui Chemicals, Inc. provided dividend guidance for the second quarter-end and year-end of FY2025. For the second quarter, the company expects to pay a dividend of JPY 75.00 per share. For the year-end, the company expects to pay dividend of JPY 75.00 per share.

Mitsui Chemicals, Inc., 2025 Earnings Call, May 13, 2025

DIGITAL GRID Corporation has completed an IPO in the amount of ¥8.25804 billion. Security Name: Shares Security Type: Common Stock Securities Offered: 250,000 Price\Range: ¥4520 Discount Per Security: ¥361.6 Security Name: Shares Security Type: Common Stock Securities Offered: 1,577,000 Price\Range: ¥4520 Discount Per Security: ¥361.6 Transaction Features: Sponsor Backed Offering

Mitsui Chemicals, Inc. (TSE:4183) proposed to acquire remaining 86.13% stake in DNA Chip Research Inc. (TSE:2397) for ¥6.4 billion on February 4, 2025. A cash consideration valued at ¥1100 per share will be paid by Mitsui Chemicals for 5,823,062 shares. The Board of Directors of DNA Chip Research Inc. formed a special committee for the transaction. The expected completion of the transaction is April 7, 2025. Mizuho Securities Co., Ltd. acted as tender offer agent and Rakuten Securities, Inc. acted as deputy agent to Mitsui Chemicals. KPMG FAS Co., Ltd. acted as financial advisor for Mitsui Chemicals, Inc. Mori Hamada & Matsumoto LPC acted as legal advisor for Mitsui Chemicals, Inc. Plutus Consulting Co., Ltd. acted as financial advisor for DNA Chip Research Inc. Nishimura & Asahi acted as legal advisor for DNA Chip Research Inc. Mitsui Chemicals, Inc. (TSE:4183) completed the acquisition of remaining 86.13% stake in DNA Chip Research Inc. (TSE:2397) on April 7, 2025. The Tender Offeror intends to conduct a series of procedures to make the Tender Offeror the only shareholder of DNA Chip Research and make the DNA Chip Research a wholly-owned subsidiary of the Tender Offeror. However, if the Squeeze-Out Procedures are carried out, DNA Chip Research Shares will be delisted through the prescribed procedures in accordance with the delisting criteria of the TSE.

Mitsui Chemicals, Inc., Board Meeting, Feb 04, 2025. Agenda: To acquire the common shares of DNA Chip Research Inc. through a tender offer and commenced the Tender Offer on February 5, 2025.

Jigyo Shokei Kiko Co., Ltd. acquired Daicel Novafoam Ltd. from Daicel Corporation (TSE:4202) and Mitsui Chemicals, Inc. (TSE:4183) on March 27, 2025. Jigyo Shokei Kiko Co., Ltd. completed the acquisition of Daicel Novafoam Ltd. from Daicel Corporation (TSE:4202) and Mitsui Chemicals, Inc. (TSE:4183) on March 27, 2025.

Mitsui Chemicals, Inc., Board Meeting, Mar 31, 2025. Agenda: To establish the Plan for the purpose of providing the Applicable Employees with incentives to achieve sustainable improvement of the Company's corporate value and to further promote shared value between the Applicable Employees and the Company's shareholders in addition to helping the Applicable Employees to build their assets by creating opportunities to acquire the Company's common shares as Restricted Shares.

Dai Nippon Printing Co., Ltd. (TSE:7912), Mitsui Chemicals, Inc. (TSE:4183) and JIC Capital Co., Ltd. entered into Memorandum of understanding to acquire an 49.98% stake in Shinko Electric Industries Co., Ltd. (TSE:6967) in a tender offer transaction from The Hachijuni Bank, Ltd. (TSE:8359), Nomura Securities Co., Ltd. and JPMorgan Securities Japan Co., Ltd. for approximately ¥400 billion on December 12, 2023. A cash consideration valued at ¥5920 per share will be paid by Dai Nippon Printing Co., Ltd., Mitsui Chemicals, Inc. and JIC Capital Co., Ltd. Upon successful completion of tender offer and execution of agreement, Japan Investment Corporation will hold 80% stake, DNP will have a 15% stake and Mitsui Chemicals will have a 5% stake. The transaction is subject to approval of merger agreement by target board. The Board of Directors of Shinko Electric Industries Co., Ltd. formed a special committee for the transaction. The deal has been approved by the board. As of August 24, 2024 the Tender Offeror commented that it expects the procedures and steps as required by these relevant competition laws will be completed and the Tender Offer will commence in or after late January 2025. As of February 17, 2025, the tender offer period will end on March 18, 2025. BofA Securities, Inc. acted as financial advisor for JIC Capital Co., Ltd. Mori Hamada & Matsumoto LPC acted as legal advisor for JIC Capital Co., Ltd. Davis Polk & Wardwell LLP acted as legal advisor for JIC Capital Co., Ltd. SMBC Nikko Securities Inc. acted as Financial advisor to Shinko Electric Industries, Nishimura & Asahi acted as legal advisor to Shinko Electric Industries. Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. acted as Financial advisor to Shinko Electric Industries. Dai Nippon Printing Co., Ltd. (TSE:7912), Mitsui Chemicals, Inc. (TSE:4183) and JIC Capital Co., Ltd. completed the acquisition of 49.98% stake in Shinko Electric Industries Co., Ltd. (TSE:6967) from The Hachijuni Bank, Ltd. (TSE:8359), Nomura Securities Co., Ltd. and JPMorgan Securities Japan Co., Ltd. on March 18, 2025.

Mitsui Chemicals, Inc. announced that they will report fiscal year 2025 results on May 13, 2025

Mitsui Chemicals, Inc. announced that its Board of Directors resolved to change its Representative Directors. Details of the changes: As of April 1, 2025. YOSHINO Tadashi: Previous Position: Representative Director, Member of the Board, Senior Managing Executive Officer. New Position: Representative Director, Member of the Board, Senior Executive Advisor. NAKAJIMA Hajime: Previous Position: Representative Director, Member of the Board, Senior Managing Executive Officer. New Position: Member of the Board, Councillor. NAKAJIMA Hajime is scheduled to retire from his position as a Member of the Board at the Company's 28th Ordinary General Meeting of Shareholders to be held on June 24, 2025, and assume the role of Councillor. As of June 24, 2025: YOSHINO Tadashi: Previous Position; Representative Director, Member of the Board, Senior Executive Advisor. New Position: Senior Executive Advisor. HIRAHARA Akio: Previous Position: Senior Managing Executive Officer. New Position: Representative Director, Member of the Board, Senior Managing Executive Officer. HIRAHARA Akio is scheduled to assume the Representative Director, Member of the Board after the resolution of the Company's 28th Ordinary General Meeting of Shareholders to be held on June 24, 2025 and the subsequent resolution of the Board of Directors meeting of the Company. Career Summary of the newly appointed Representative Director: HIRAHARA Akio Date of Birth: October 7, 1963. April, 1987 Joined the Company June, 2005 Director, Nonwovens Department, Functional Fabricated Products Div. April, 2010 General Manager, New Market Development Automotive MaterialsDiv. April, 2014 Senior Director, General Manager, New Market DevelopmentAutomotive MaterialsDiv. April, 2016 Executive Officer, General Manager, New Mobility Business Development Div. April, 2017 Executive Officer, General Manager, Corporate Planning Div. April, 2019 Managing Executive Officer, In charge of Corporate Planning Div. and Information System Div. April, 2020 Managing Executive Officer, In charge of Corporate Planning Div., Information System Div., Corporate Sustainability Div. and Corporate Sustainability Committee April, 2022 Senior Managing Executive Officer, Business Sector President, ICT Solutions Business Sectorto present.

Mitsui Chemicals, Inc. has completed a Fixed-Income Offering in the amount of ¥8 billion. Security Name: 1.976% Unsecured Straight Bonds due February 27, 2035 Security Type: Corporate Bond/Note (Non Convertible) Principal Amount: ¥8 billion Price\Range: 100% Security Features: Unsecured Coupon Type: Fixed

Mitsui Chemicals, Inc. has completed a Fixed-Income Offering in the amount of ¥20 billion. Security Name: 1.365% Unsecured Straight Bonds due February 27, 2030 Security Type: Corporate Bond/Note (Non Convertible) Principal Amount: ¥20 billion Price\Range: 100% Security Features: Unsecured Coupon Type: Fixed

Mitsui Chemicals, Inc. has completed a Fixed-Income Offering in the amount of ¥12 billion. Security Name: 1.150% Unsecured Straight Bonds due February 25, 2028 Security Type: Corporate Bond/Note (Non Convertible) Principal Amount: ¥12 billion Price\Range: 100% Security Features: Unsecured Coupon Type: Fixed

Mitsui Chemicals, Inc. provided consolidated earnings guidance for fiscal year 2024. For the year, the company expects sales revenue to be JPY 1,825.0 billion, an increase of JPY 75.3 billion compared to the previous year. Operating income before special items is expected to be JPY 105.0 billion, an increase of JPY 8.8 billion from the previous year, and net income attributable to owners of the parent is expected to be JPY 56.0 billion, an increase of JPY 6.0 billion from the previous year. Compared to the previous year, the company expects operating income before special items to increase due to increases in sales volume and the impact of yen depreciation in the specialty chemicals domains as well as improved terms of trade due to sales price increases and inventory valuation gains in Basic & Green Materials. Consequently, the projected increase in operating income before special items of JPY 8.8 billion over the previous year is attributable to a number of factors, including a positive volume difference of JPY 26.0 billion, a positive terms of trade impact of JPY 5.0 billion and a negative impact of fixed costs and others of JPY 22.2 billion.

Mitsui Chemicals, Inc. provided dividend guidance for the full year 2024. Regarding shareholder returns, the dividend outlook is JPY 150 per share for the full year, an increase of JPY 10 from the previous year.

Informa Markets Limited, ProPak Asia 2025, Jun 11, 2025 through Jun 14, 2025. Venue: Bangkok International Trade & Exhibition Centre (BITEC), Bangkok, Thailand.

Mitsui Chemicals, Inc. (TSE:4183) proposed to acquire remaining 86.13% stake in DNA Chip Research Inc. (TSE:2397) for ¥6.4 billion on February 4, 2025. A cash consideration valued at ¥1100 per share will be paid by Mitsui Chemicals for 5,823,062 shares. The Board of Directors of DNA Chip Research Inc. formed a special committee for the transaction. The expected completion of the transaction is April 7, 2025. Mizuho Securities Co., Ltd. acted as tender offer agent and Rakuten Securities, Inc. acted as deputy agent to Mitsui Chemicals. KPMG FAS Co., Ltd. acted as financial advisor for Mitsui Chemicals, Inc. Mori Hamada & Matsumoto LPC acted as legal advisor for Mitsui Chemicals, Inc. Plutus Consulting Co., Ltd. acted as financial advisor for DNA Chip Research Inc. Nishimura & Asahi acted as legal advisor for DNA Chip Research Inc.

Mitsui Chemicals, Inc., Q3 2025 Earnings Call, Feb 04, 2025

Mitsui Chemicals, Inc. expected to report Fiscal Year 2025 results on May 12, 2025. This event was calculated by S&P Global (Created on January 10, 2025).

Mitsui Chemicals, Inc. - Special Call

The company closed its plan on December 20, 2024.

From November 22, 2024 to December 20, 2024, the company has repurchased 2,828,100 shares, representing 1.49% for ¥9,999.74 million. With this, the company has completed the repurchase of 2,828,100 shares, representing 1.49% for ¥9,999.74 million under the buyback announced on November 22, 2024.

Mitsui Chemicals, Inc. announced that they will report Q3, 2025 results on Feb 04, 2025

Mitsui Chemicals, Inc. (TSE:4183) announces a share repurchase program. Under the program, the company will repurchase 3,200,000 shares, representing 1.68% of its share capital, for ¥10,000 million. The company will repurchase its shares in order to enhance shareholder returns and improve capital efficiency. The repurchase program will continue until February 28, 2025. As of October 31, 2024, the company had 190,171,800 shares outstanding (excluding treasury shares) and 110,672,015 shares in treasury.

The Board of Directors of Mitsui Chemicals, Inc. has authorized a buyback plan on November 22, 2024.

Mitsui Chemicals, Inc., ¥ 75.0, Cash Dividend, Mar-28-2025

Mitsui Chemicals, Inc. expected to report Q3 2025 results on January 31, 2025. This event was calculated by S&P Global (Created on November 7, 2024).

Mitsui Chemicals, Inc., Q2 2025 Earnings Call, Nov 07, 2024

Mitsui Chemicals, Inc. and Idemitsu Kosan Co. Ltd. have been engaged in deliberations on optimizing production by consolidating their ethylene facilities in the Chiba region. As the two companies have recently completed the feasibility study (FS), they now intend to move on to the next phase - front-end engineering and design (FEED). In 2010, Mitsui and Idemitsu used a limited liability partnership (LLP) to establish Chiba Chemicals Manufacturing LLP and began jointly operating the ethylene facilities owned by both companies in the Chiba region in order to optimize production. Under this structure, the two companies have fastidiously pursued synergies. However, Japanese ethylene facilities continue to be forced to operate at a low rate due to both the opening of large new and expanded petrochemical complexes, mainly in China, and the diminishing domestic demand for ethylene. As such, the petrochemical business environment within Japan is expected to become even tougher. Amid these environmental changes, the two companies conducted an FS focused on consolidating their ethylene facilities in the Chiba region into a single unit at Mitsui's current facility, as announced on March 27, 2024. The FS examined the impact of consolidating the ethylene facilities on feedstock procurement, as well as on the production and supply setup for the products involved. As the two companies reached the conclusion that consolidation will be feasible, they have agreed to move on to the FEED phase. FEED premises for the consolidation of ethylene facilities in the Chiba region: Planned timing of consolidation: Fiscal 2027, Consolidation method: Closure of Idemitsu's facility and consolidation of production at Mitsui's facility, Feedstock for the ethylene facility: To be supplied to the LLP by both companies, Products involved: All fractions, including ethylene, propylene and C4*3, Business format after consolidation: Continuation of the current LLP and joint operation of Mitsui's facility by that LLP. Timing of decision: Latter half of fiscal 2025 After conducting FEED, the two companies plan to discuss the potential consolidation and then reach a final decision. The companies will step up the pace of deliberations in order to achieve greater production efficiency at their ethylene facilities and thereby enhance their competitiveness.

Rege Nephro Co., Ltd. announced that it will receive ¥25,000 million in a round of funding led by new investor, DCI Partners Co., Ltd. on October 7, 2024. The transaction will include participation from mix of strategic investors including new investors, JIC Venture Growth Investments Co., Ltd., Nippon Venture Capital Co., Ltd., Tohoku University Venture Partners Co.,Ltd., Golden Asia Fund Venture Ltd., Mitsui Chemicals, Inc., Global Brain Corporation, Mitsubishi UFJ Capital Co., Ltd., Industrial Technology Investment Corporation, Shimadzu Corporation, SCREEN Holdings Co., Ltd., Chushin Venture Capital Co., Ltd., Senshu Ikeda Capital Co., Ltd., Toyo Seikan Group Holdings, Ltd., Asahi Kasei Corporation, QB Capital, LLC and i-Lab CVC1 Limited Liability Partnership, and returning investor, Kyoto University Innovation Capital Co., Ltd., JAFCO Group Co., Ltd., and other investors. On the same date, the company has received ¥22,500 million in its first tranche. The company has raised a total of ¥44,000 million in funding till date.

Mitsui Chemicals, Inc. announced that they will report Q2, 2025 results on Nov 07, 2024

Mitsui Chemicals, Inc., Q1 2025 Earnings Call, Aug 06, 2024